All research
Oxytocin 2026-04 ClinicalTrials

Oxytocin concentrations hypothesized to decrease with induced self-dehumanization, mediating suicide risk

Inducing Self-Dehumanization to Examine Oxytocin and Suicide Risk

Background

Understanding the complex factors contributing to suicide risk is critical for developing effective interventions. Self-dehumanization, perceiving oneself as less than human or machine-like, is emerging as a potential novel psychological risk factor. Simultaneously, oxytocin (OXT), a neuropeptide known for its roles in social bonding and stress regulation, has been implicated in various psychiatric conditions, including mood disorders and anxiety. The precise interplay between self-dehumanization, neurobiological markers like oxytocin, and the acute onset of suicidal ideation remains underexplored, representing a significant gap in current suicide prevention research.

Study Design

This experimental protocol outlines a three-day study: one screening day and two study days. Participants will be randomly assigned to either a self-dehumanized mechanistic future condition or a control group. The experimental condition will induce self-dehumanization using a novel futuristic paradigm that likens the individual to a machine. On the screening day, participants receive a saline nasal spray, introduced as oxytocin, to establish treatment expectations via a validated protocol. The primary endpoints include changes in suicidal ideation (thoroughly assessed and intervened upon) and oxytocin concentrations (measured via unspecified assay) between the groups, with the magnitude of the oxytocin response explored as a partial mediator.

Results

This study describes a research protocol and its hypotheses, rather than presenting completed findings. The central hypothesis posits that participants in the self-dehumanized mechanistic future condition will exhibit temporary increases in suicidal ideation and corresponding decreases in oxytocin concentrations when compared to the control group. The control condition is not expected to show significant changes in these measures. Furthermore, the research aims to explore if the magnitude of the oxytocin response will partially mediate the observed change in suicidal ideation. This design seeks to establish a causal link between induced self-dehumanization, neurobiological changes, and acute suicide risk. The study emphasizes that any temporary increases in suicidal ideation will be thoroughly assessed and immediately intervened upon following the induction.

Key Findings

  • Hypothesis: Induced self-dehumanization will temporarily increase suicidal ideation.
  • Hypothesis: Induced self-dehumanization will temporarily decrease oxytocin concentrations.
  • Hypothesis: Oxytocin response magnitude will partially mediate changes in suicidal ideation.

Why It Matters

If the hypotheses of this protocol are confirmed, it would establish self-dehumanization as a measurable and inducible risk factor for acute suicidal ideation, directly linked to oxytocin dysregulation. This could open new avenues for understanding and potentially intervening in suicide risk. For clinicians and researchers, identifying a neurobiological correlate like oxytocin could lead to novel diagnostic biomarkers or therapeutic targets. While this is a foundational experimental study, a successful outcome could inform the development of psychological interventions that mitigate self-dehumanizing thoughts or pharmacological strategies that modulate oxytocin pathways to reduce suicide risk. The protocol's emphasis on immediate intervention for induced suicidal ideation highlights the ethical rigor required for such sensitive research.


oxytocin suicide-risk self-dehumanization neuropeptide experimental-protocol psychiatry
Source: clinicaltrials:NCT06710964 · Ingested 2026-06-03 · Digest: gemini-2.5-flash